Update on FTC Administrative Complaint Against Illumina Lanton Law has been monitoring the developments around the FTC’s administrative complaint against Illumina on marketplace competition concerns. We have recently shared an industry blog about this issue. Read More biotechnology, cancer, FTC, healthcareRon LantonJune 2, 2021Illumina, liquid biopsy, GRAIL, cancer, oncology, FTC
